An optimized growth factor cocktail for ovine mesenchymal stem cells

References

• Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW. 2005. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci USA. 102 32: 11474–11479.
   PubMed Web of Science ®Google Scholar
• An C, Cheng Y, Yuan Q, Li J. 2010. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocyte-like cells. Ann Biomed Eng. 38 4: 1647–1654.
   PubMed Web of Science ®Google Scholar
• Antala A. 2007. Engineering tissues, organs and cells. J Tissue Eng Regen Med. 1:83–96.
   PubMedGoogle Scholar
• Assis C, Carvalho JL, Jacoby BA, Ferreira RL, Castanheira P, Diniz SO, Cardoso VN, Goes AM, Ferreira AJ. 2010. Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart. Cell Transplant. 19:219–230.
   PubMed Web of Science ®Google Scholar
• Baraki H, Tudorache I, Braun M, Höffer K, Görler A, Lichtenberg A, Bara C, Calistru A, Brandes G, Hewicker-Trautwein M, Hilfiker A, Haverich A, Cebotari S. 2009. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials. 30 31: 6240–6246.
   PubMed Web of Science ®Google Scholar
• Binger T, Stich S, Andreas S, Kaps C, Sezer O, Notter M, Sittinger M, Ringe J. 2009. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 315 8: 1468–1479.
   PubMed Web of Science ®Google Scholar
• Bocchi L, Savi M, Graiani G, Rossi S, Agnetti A, Stillitano F, Lagastra C, Baruffi S, Berni R, Frati C, Vassalle M, Squarcia U, Cerbai E, Macchi E. 2011. Growth factor-induced mobilization of cardiac progenitor cells reduces the risk of arrhythmias, in a rat model of chronic myocardial infarction. PloS One. 6 3: e177750.
   Google Scholar
• Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, Chopp M. 2001. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 32:1005–1011.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop DJ, Horwitz E. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 8 4: 315–317.
   PubMed Web of Science ®Google Scholar
• Fuchs JR, Hannouche D, Terada S, Zand S, Vacanti JP, Fauza DO. 2005. Cartilage engineering from ovine umbilical cord blood mesenchymal progenitor cells. Stem Cells. 23:958–964.
   PubMedGoogle Scholar
• Grayson WL, Ma T, Bunnell B. 2004. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog. 20:905–912.
   PubMed Web of Science ®Google Scholar
• Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ. 2003. Molecular and cellular characterisation of highly purified stromal cells derived from human bone marrow. J Cell Sci. 116 9: 1827–1835.
   PubMedGoogle Scholar
• Hamamoto H, Gorman JH, Ryan LP, Hinmon R, Martens TP, Schuster MD, Plappert T, Kiupel M, St John-Sutton MG, Itescu S, Gorman RC. 2009. Allogeneic mesenchymal progenitor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. Ann Thorac Surg. 87 3: 794–801.
   PubMedGoogle Scholar
• Jager M, Bachmann R, Scharfstadt A, Krauspe R. 2006. Ovine cord blood accommodates multipotent mesenchymal progenitor cells. In Vivo. 20:205–214.
   PubMedGoogle Scholar
• Johnstone B, Hering TM, Caplan AI, Goldberg VM, Yoo JU. 1998. In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Exp Cell Res. 238:265–272.
   PubMed Web of Science ®Google Scholar
• Jorgensen C, Gordeladze J, Noel D. 2004. Tissue engineering through autologous mesenchymal stem cells. Curr Opin Biotechnol. 15:406–410.
   PubMed Web of Science ®Google Scholar
• Kim H, Kim U, Vunjak-Novakovic G, Min B, Kaplan DL. 2005. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials. 26:4442–4452.
   PubMed Web of Science ®Google Scholar
• Kratchmarova I, Blagoev B, Haack-Sorensen M, Kassem M, Mann M. 2005. Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation. Science. 308:1472–1477.
   PubMed Web of Science ®Google Scholar
• Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A. 2007. Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev. 16 1: 31–37.
   PubMedGoogle Scholar
• McCarty RC, Gronthos S, Zannettino AC, Foster BK, Xian CJ. 2009. Characterisation and developmental potential of ovine bone marrow derived mesenchymal stem cells. J Cell Physiol. 219:324–333.
   PubMed Web of Science ®Google Scholar
• Miller ED, Li K, Kanade T, Weiss LE, Walker LM, Campbell PG. 2011. Spatially directed guidance of stem cell population migration by immobilized patterns of growth factors. Biomaterials. 32 11: 2775–2785.
   PubMedGoogle Scholar
• Mrugala D, Bony C, Neves N, Caillot L, Fabre S, Moukoko D, Jorgensen C, Noël D. 2008. Phenotypic and functional characterization of ovine mesenchymal stem cells: application to a cartilage defect model. Ann Rheum Dis. 67:288–295.
   PubMed Web of Science ®Google Scholar
• Narine K, De Wever O, Van Valckenborgh D, Francois K, Bracke M, De Smet S, Mareel M, Van Nooten G. 2006. Growth factor modulation of fibroblast proliferation, differentiation, and invasion: Implications for tissue valve engineering. Tissue Eng. 12 10: 2707–2716.
   PubMedGoogle Scholar
• Perin EC, Silva GV, Assad JA, Vela D, Buja LM, Sousa AL, Litovsky S, Lin J, Vaughn WK, Coulter S, Fernandes MR, Willerson JT. 2008. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J Mol Cell Cardiol. 44 3: 486–495.
   PubMed Web of Science ®Google Scholar
• Perry TE, Kaushal S, Sutherland FW, Guleserian KJ, Bischoff J, Sacks M, Mayer JE. 2003. Thoracic surgery directors association award. Bone marrow as a cell source for tissue engineering heart valves. Ann thorac Surg. 75 3: 761–767.
   PubMed Web of Science ®Google Scholar
• Ponte AL, Marais E, Gallay N, Langonné A, Delorme B, Hérault O, Charbord P, Domenech J. 2007. The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells. 25 7: 1737–1745.
   PubMed Web of Science ®Google Scholar
• Schenk S, Mal N, Finan M, Zhang M, Kiedrowki Z, Popovic P, McCarthy M, Penn MS. 2007. Monocyte chemotactic protein-3 is a myocardia mesenchymal stem cell homing factor. Stem Cells. 25:245–251.
   PubMed Web of Science ®Google Scholar
• Silva GV, Litovsky S, Assad JA, Sousa AL, Martin BJ, Vela D, Coulter SC, Lin J, Ober J, Vaughn WK, Branco RV, Oliveira EM, He R, Geng YJ. 2005. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation. 111 2: 150–156.
   PubMed Web of Science ®Google Scholar
• Somers P, Narine K, De Somer F, De Vos F, Van Nooten G. 2008. Sustained release and activation of the growth factor basic fibroblast growth factor from loaded scaffolds in heart valve tissue engineering. Growth Factors. 26 5: 293–299.
   PubMed Web of Science ®Google Scholar
• Spaeth E, Klopp A, Dembinski J, Andreeff M, Marini F. 2008. Inflammation and tumor microenvironments: Defining the migratory itinerary of mesenchymal stem cells. Gene Ther. 15 10: 730–738.
   PubMed Web of Science ®Google Scholar
• Van Nooten G, Somers P, Cornelissen M, Bouchez S, Gasthuys F, Cox E, Sparks L, Narine K. 2006. Acellular porcine and kangaroo aortic valve scaffolds show more intense immune-mediated calcification than cross-linked Toronto SPV valves in the sheep model. Interact Cardiovasc Thorac Surg. 5 5: 544–549.
   PubMedGoogle Scholar
• Vesely I. 2005. Heart valve tissue engineering. Circ Res. 97:743–755.
   Google Scholar
• Vincentelli A, Wautot F, Juthier F, Fouquet O, Corseaux D, Marechaux S, Le Toutneau T, Fabre O, Susen S, Van Belle E, Mouquet F, Decoene C, Prat A, Jude B. 2007. In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates?. J Thorac Cardiovasc Surg. 134:424–432.
   PubMed Web of Science ®Google Scholar
• Wang Q, McGoron AJ, Kato Y, Pinchuk L, Schoephoerster RT. 2010. In-vivo assessment of a novel polymer (SIBS) trileaflet heart valve. J Heart Valve Dis. 19 4: 499–505.
   PubMed Web of Science ®Google Scholar
• Wang JJ, Ye F, Cheng LJ, Shi YJ, Bao J, Sun HQ, Wang W, Zhang P, Bu H. 2009. Osteogenic differentiation of mesenchymal stem cells promoted by overexpression of connective tissue growth factor. J Zhejiang Univ Sci B. 10 5: 355–367.
   PubMed Web of Science ®Google Scholar